tiprankstipranks
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market
Holding TSE:BUX?
Track your performance easily

BioMark Diagnostics (BUX) Financial Statements

3 Followers

BioMark Diagnostics Financial Overview

BioMark Diagnostics's market cap is currently ―. The company's EPS TTM is C$-0.022; its P/E ratio is ―; BioMark Diagnostics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 38.35K$ 38.31K$ 39.80K$ 41.54K$ 42.13K
Gross Profit$ 38.35K$ 38.31K$ 39.80K$ 41.54K$ 42.13K
EBIT$ -530.74K$ -604.30K$ -339.86K$ -386.69K$ -192.12K
EBITDA$ -472.57K$ -546.54K$ -239.01K$ -287.65K$ -101.60K
Net Income Common Stockholders$ -547.31K$ -623.28K$ -391.31K$ -406.76K$ -210.46K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 34.65K$ 141.36K$ 156.75K$ 313.03K$ 168.44K
Total Assets$ 877.84K$ 1.01M$ 1.09M$ 1.35M$ 632.24K
Total Debt$ 635.64K$ 721.96K$ 805.93K$ 1.08M$ 516.44K
Net Debt$ 601.00K$ 580.60K$ 649.18K$ 770.53K$ 347.99K
Total Liabilities$ 1.91M$ 1.66M$ 1.70M$ 1.91M$ 1.78M
Stockholders Equity$ -1.03M$ -649.61K$ -609.61K$ -559.77K$ -1.15M
Cash Flow-
Free Cash Flow--$ -215.70K$ -508.63K$ -12.81K
Operating Cash Flow-$ -320.69K$ -214.47K$ -506.43K$ -11.85K
Investing Cash Flow-$ -2.51K$ -1.24K$ -2.20K$ -957.00
Financing Cash Flow-$ 307.81K$ 59.42K$ 653.22K$ 6.02K
Currency in USD

BioMark Diagnostics Earnings and Revenue History

BioMark Diagnostics Debt to Assets

BioMark Diagnostics Cash Flow

BioMark Diagnostics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis